Bluesky Facebook Reddit Email

Promising new strategy to halt pancreatic cancer metastasis

Researchers found that a secreted immune protein called interleukin(IL)-17B promotes pancreatic cancer growth and metastasis. Treating tumor-bearing mice with an IL-17B inhibitor halted tumor growth and spread, resulting in increased survival.

Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

How the landscape of the pancreatic cancer genome is coming into view

A study of 100 pancreatic cancer genomes identifies four subtypes, including 'stable', 'locally rearranged', 'scattered', and 'unstable' genomes. The analysis suggests that patients with 'unstable' genomes respond well to platinum-based drugs and PARP inhibitors, offering a promising lead for personalized treatment.

DJI Air 3 (RC-N2)

DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.

Potential pancreatic cancer treatment could increase life expectancy

Researchers at UNC Chapel Hill have developed a device that can deliver chemotherapy drugs directly into tumor tissue, allowing for potential life-saving surgeries and increased life expectancy. The device uses electric fields to target poorly vascularized tumors, which are difficult to treat with standard IV chemotherapy drugs.

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Fox Chase researchers reveal how pancreatic cancer cells sidestep chemotherapy

Fox Chase researchers discovered that pancreatic cancer cells sidestep chemotherapy by hijacking the vitamin D receptor, a key mechanism driving chemotherapeutic effectiveness against pancreatic cancer. The findings raise hopes for developing new treatments that can selectively kill cancer cells while leaving healthy cells unharmed.

Scientists announce revolutionary culturing technique for liver and pancreas

Scientists have developed a breakthrough culturing system for human liver stem cells and pancreatic cancer stem cells, allowing for the growth of mini-organisms in the lab. This technology has the potential to revolutionize liver transplantation and aid in the fight against pancreatic cancer, with applications in personalized medicine.

Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Armed virus shows promise as treatment for pancreatic cancer

A study led by Dr Yaohe Wang at Barts Cancer Institute found that arming a modified virus called Vaccinia with a specific gene enhanced its effectiveness against pancreatic cancer. In mice, the armed virus was more effective in killing tumors and preventing regrowth compared to an unarmed version.

Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Genes that cause pancreatic cancer identified by new tool

A new technique has uncovered large sets of previously unknown pancreatic cancer genes by introducing DNA transposons into mouse genomes. The study found that the Foxp1 gene drives cancer progression and is highly expressed in human cancers that have metastasised.

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

IU researchers: Blood test may help to diagnose pancreatic cancer

Researchers at Indiana University have found that a panel of microRNAs in plasma can accurately diagnose pancreatic ductal adenocarcinoma, the most common type of pancreatic malignancy. The discovery could lead to a blood test for early detection and potentially improve treatment outcomes.

Early detection window when pancreatic cancer is in the family

Researchers found a potential early detection window for pancreatic cancer in people with a family history of the disease. The study suggests that identifying susceptibility genes and designing risk management programs can help detect the disease earlier, improving outcomes.

Researchers identify early sign of pancreatic cancer

A team of scientists identified a rise in branched-chain amino acids as an early indicator of pancreatic cancer development, occurring years before symptoms appear. The breakthrough discovery has the potential to spur progress in detecting and treating the disease.

GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Modified vitamin D shows promise as treatment for pancreatic cancer

Researchers found that a synthetic derivative of vitamin D can collapse the barrier of cells shielding pancreatic tumors, making them more susceptible to therapeutic drugs. Human trials are underway for pancreatic cancer, and the findings may have implications for other tough-to-treat tumors.

Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.

Wild berry extract may strengthen effectiveness of pancreatic cancer drug

Researchers found that chokeberry extract killed off cancer cells and boosted the effectiveness of chemotherapy drug gemcitabine in treating pancreatic cancer. The extract's anti-cancer properties were tested on human pancreatic cancer cells, with results suggesting a potential synergy between the two.

Wild berry extract may strengthen effectiveness of pancreatic cancer drug

A study published in the Journal of Clinical Pathology suggests that adding a wild berry extract to chemotherapy cycles may improve treatment outcomes for pancreatic cancer. The researchers found that the extract induced cell death and boosted the effectiveness of the conventional drug gemcitabine.

New trick for 'old' drug brings hope for pancreatic cancer patients

Researchers at Cancer Research UK have found a new use for an old drug, rapamycin, in shrinking and stopping the spread of a specific type of pancreatic cancer tumour. The study suggests that targeting mTOR dependency may be a key to tailoring treatment to individual patients.

Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

The inhibition of a protein opens the door to the treatment of pancreatic cancer

Researchers at IMIM have identified galectin-1 as a potential therapeutic target for pancreatic cancer, demonstrating improved survival rates of 20% in mice. The inhibition of this protein mainly affects the immune system and surrounding tumor cells, suggesting a new strategy for treating pancreatic cancer with minimal side effects.

CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Continued use of low-dose aspirin may lower pancreatic cancer risk

A study published by the American Association for Cancer Research found that low-dose aspirin significantly reduces the risk of pancreatic cancer. The longer a person takes low-dose aspirin, the lower their risk of developing pancreatic cancer, with some evidence suggesting a greater reduction in risk over time.

Endoscope with an oxygen sensor detects pancreatic cancer

Researchers at Mayo Clinic have developed an optical blood oxygen sensor attached to an endoscope that can identify pancreatic cancer with a sensitivity of 92% and specificity of 86%. The device measures changes in blood flow near the pancreas, which tumors alter to grow. Early detection is crucial as most pancreatic cancers are diagno...

Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Short nanotubes target pancreatic cancer

Researchers at Rice University have developed customized carbon nanotubes that can deliver chemotherapy agents to pancreatic cancer cells. The nanotubes are small enough to pass through the pores of cancer-related blood vessels, allowing them to target and infiltrate the nuclei of cancerous cells.

New therapy for pancreatic cancer patients shows promising results

A new drug called MM-398 has shown a significant overall survival rate in patients with advanced pancreatic cancer when given in combination with 5-flourouracil and leucovorin. The study achieved an overall survival of 6.1 months, a 1.9 month improvement over the control arm.

Study explains how green tea could reduce pancreatic cancer risk

A recent study published in Metabolomics found that EGCG, a green tea extract, disrupts the balance of metabolic pathways in pancreatic cancer cells, reducing their growth and increasing the risk of cancer. Researchers also identified an enzyme inhibitor, oxamate, which operates in a similar manner.

Salk professor named grantee in new pancreatic cancer research program

Ronald M. Evans, director of the Gene Expression Laboratory at Salk Institute, is one of three scientists chosen for The Lustgarten Foundation's Distinguished Scholars program to focus on finding a cure for pancreatic cancer. He will expand his research on Vitamin D therapies using clinical trials in patients.

Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Gene mutation found for aggressive form of pancreatic cancer

Researchers have discovered a unique molecular signature for adenosquamous carcinoma (ASC), a rare and virulent form of pancreatic cancer. The identification of somatic mutations in the UPF1 gene may lead to the development of novel diagnostic approaches and therapeutic strategies, offering new hope for patients with ASC.

Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Bacteria in mouth may diagnose pancreatic cancer

Researchers found distinct profiles of bacteria in saliva that may indicate early-stage pancreatic cancer diagnosis. High levels of Leptotrichia and Campylobacter were detected in patients with pancreatic cancer compared to healthy controls.

'Achilles heel' of pancreatic cancer identified

Researchers at Georgetown University Medical Center have identified Yes-associated protein (Yes) as the critical switch that promotes cancer growth and progression in pancreatic ductal adenocarcinoma (PDAC). Inhibiting Yes completely shuts down further growth of pancreatic cancer, offering a promising therapeutic target.

Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

Pancreatic cancer 'dream team' tackles baffling, deadly disease

Researchers from the University of California - San Francisco, led by Margaret Tempero, are part of a national 'dream team' working to accelerate treatment and discoveries for pancreatic cancer. The team aims to turn the deadly disease into a treatable one through targeted approaches and collaborative research.

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

New SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team announced

The SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team aims to develop new therapies using patients' own immune cells to treat pancreatic cancer. The team, led by experts in various institutions, will focus on understanding the tumor microenvironment and developing therapeutic agents to eliminate barriers to treatment.